Spots Global Cancer Trial Database for antineoplastic agents, combined
Every month we try and update this database with for antineoplastic agents, combined cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease | NCT00000626 | HIV Infections Hodgkin's Disea... | Vinblastine sul... Dacarbazine Filgrastim Bleomycin sulfa... Doxorubicin hyd... | 12 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma | NCT00000801 | Lymphoma, Non-H... HIV Infections | Filgrastim Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Cytarabine Dexamethasone | 16 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members | NCT00000703 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Allopurinol Methotrexate Cytarabine Leucovorin calc... Zidovudine Dexamethasone | 19 Years - 69 Years | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma | NCT00000689 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Methotrexate Cytarabine Leucovorin calc... Sargramostim Dexamethasone | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma | NCT00000801 | Lymphoma, Non-H... HIV Infections | Filgrastim Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Cytarabine Dexamethasone | 16 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members | NCT00000703 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Allopurinol Methotrexate Cytarabine Leucovorin calc... Zidovudine Dexamethasone | 19 Years - 69 Years | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma | NCT00000658 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Allopurinol Methotrexate Cytarabine Leucovorin calc... Sargramostim Dexamethasone | 12 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma | NCT00000801 | Lymphoma, Non-H... HIV Infections | Filgrastim Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Cytarabine Dexamethasone | 16 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma | NCT00000689 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Methotrexate Cytarabine Leucovorin calc... Sargramostim Dexamethasone | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma | NCT00000658 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Allopurinol Methotrexate Cytarabine Leucovorin calc... Sargramostim Dexamethasone | 12 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Novel Adjuvants for Peptide-Based Melanoma Vaccines | NCT00028431 | Melanoma | MDX-CTLA4 Antib... | 18 Years - | University of Southern California |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
